Federal Register / Vol. 86, No. 124 / Thursday, July 1, 2021 / Notices 35093 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in paragraph 7 of 

the Act. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than July 16, 2021. 

A. Federal Reserve Bank of St. Louis 

(Holly A. Rieser, Manager) P.O. Box 442, 

St. Louis, Missouri 63166–2034. 

Comments can also be sent 

electronically to 

Comments.applications@stls.frb.org: 

1. Steuart L. Walton, Thomas L. 

Walton, Alice A. Proietti, and James M. 

Walton, all of Bentonville, Arkansas; to 

become members of the Walton Family 

Group, a group acting in concert to 

retain voting shares of Arvest Bank 

Group, Inc., Bentonville, Arkansas, and 

thereby indirectly retain voting shares of 

Arvest Bank, Fayetteville, Arkansas. 

Board of Governors of the Federal Reserve 

System, June 28, 2021. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2021–14126 Filed 6–30–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Meeting of the National Advisory 

Council for Healthcare Research and 

Quality 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of public meeting. 

SUMMARY: This notice announces a 

meeting of the National Advisory 

Council for Healthcare Research and 

Quality. 

DATES: The meeting will be held on 

Wednesday, July 14, 2021, from 10:00 

a.m. to 2:30 p.m. 

ADDRESSES: The meeting will be held 

virtually. 

FOR FURTHER INFORMATION CONTACT: 

Jaime Zimmerman, Designated 

Management Official, at the Agency for 

Healthcare Research and Quality, 5600 

Fishers Lane, Mail Stop 06E37A, 

Rockville, Maryland 20857, (301) 427– 

1456. For press-related information, 

please contact Bruce Seeman at (301) 

427–1998 or Bruce.Seeman@

AHRQ.hhs.gov. 

Closed captioning will be provided 

during the meeting. If another 

reasonable accommodation for a 

disability is needed, please contact the 

Food and Drug Administration (FDA) 

Office of Equal Employment 

Opportunity and Diversity Management 

on (301) 827–4840, no later than Friday, 

July 2, 2021. The agenda, roster, and 

minutes will be available from Ms. 

Heather Phelps, Committee 

Management Officer, Agency for 

Healthcare Research and Quality, 5600 

Fishers Lane, Rockville, Maryland 

20857. Ms. Phelps’ phone number is 

(301) 427–1128. 

SUPPLEMENTARY INFORMATION: 

I. Purpose 

In accordance with section 10(a) of 

the Federal Advisory Committee Act, 5 

U.S.C. App., this notice announces a 

meeting of the National Advisory 

Council for Healthcare Research and 

Quality (the Council). The Council is 

authorized by Section 941 of the Public 

Health Service Act, 42 U.S.C. 299c. In 

accordance with its statutory mandate, 

the Council is to advise the Secretary of 

the Department of Health and Human 

Services and the Director of AHRQ on 

matters related to AHRQ’s conduct of its 

mission including providing guidance 

on (A) priorities for health care research, 

(B) the field of health care research 

including training needs and 

information dissemination on health 

care quality and (C) the role of the 

Agency in light of private sector activity 

and opportunities for public private 

partnerships. The Council is composed 

of members of the public, appointed by 

the Secretary, and Federal ex-officio 

members specified in the authorizing 

legislation. 

II. Agenda 

On Wednesday, July 14, 2021, the 

Council meeting will convene at 10:00 

a.m., with the call to order by the 

Council Chair and approval of previous 

Council summary notes. The meeting 

will begin with an update on AHRQ’s 

recent accomplishments in Health 

Systems Research, Practice 

Improvement, and Data and Analytics. 

The agenda will also include 

discussions on Strategic Opportunities 

for FY22, Opportunities to Advance 

Telehealth and Advancing Patient 

Safety. The meeting will adjourn at 2:30 

p.m. The meeting is open to the public. 

For information regarding how to access 

the meeting as well as other meeting 

details, including information on how to 

make a public comment, please go to 

https://www.ahrq.gov/news/events/nac/. 

The final agenda will be available on the 

AHRQ website no later than 

Wednesday, July 7, 2021. 

Dated: June 25, 2021. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2021–14010 Filed 6–30–21; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2021–0060] 

Advisory Committee on Immunization 

Practices (ACIP); Cancellation of 

Meeting 

Notice is hereby given of a change in 

the meeting of the Advisory Committee 

on Immunization Practices (ACIP); June 

18, 2021, 11:00 a.m. to 5:00 p.m., EDT 

(dates and times subject to change), in 

the original FRN. 

The virtual meeting was published in 

the Federal Register on June 15, 2021, 

Volume 86, Number 113, pages 31716– 

31717. 

Due to the Federal holiday on June 18, 

2021, the ACIP meeting has been 

canceled in its entirety. In addition, the 

previously scheduled June 18, 2021 

agenda items will be discussed at the 

ACIP meeting on June 23–25, 2021. 

Additionally, public comments 

submitted to docket number CDC–2021– 

0060 will be shared with ACIP members 

at or prior to the June 23–25, 2021 

meeting. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, Centers for 

Disease Control and Prevention, 

National Center for Immunization and 

Respiratory Diseases, 1600 Clifton Road 

NE, MS–H24–8, Atlanta, Georgia 30329– 

4027; Telephone: (404) 639–8367; 

Email: ACIP@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 


khammond on DSKJM1Z7X2PROD with NOTICES
35094 Federal Register / Vol. 86, No. 124 / Thursday, July 1, 2021 / Notices 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–14007 Filed 6–30–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee (HICPAC) Meeting 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Healthcare Infection Control 

Practices Advisory Committee 

(HICPAC). This virtual meeting is open 

to the public, limited only by audio and 

web conference lines (300 audio and 

web conference lines are available). 

Registration is required. To register for 

this web conference, please go to: 

www.cdc.gov/hicpac. All registered 

participants will receive the meeting 

link and instructions shortly before the 

meeting. 

DATES: The meeting will be held on 

August 19, 2021, from 12:00 p.m. to 2:00 

p.m., EDT. 

ADDRESSES: Please click the link below 

to join the webinar: https://

cdc.zoomgov.com/j/1612908106?

pwd=M0xTVWxmUTRtZXhu

OVBzWmsybFZxZz09. 

Meeting ID: 161 290 8106 

Passcode: yq!BLL44 

Dial-in Lines: 

+1–669–254–5252 (San Jose) 

+1–646–828–7666 (New York) 

Meeting ID: 161 290 8106 

Telephone Passcode: 47632330. 

FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC, 

Division of Healthcare Quality 

Promotion, NCEZID, CDC, 1600 Clifton 

Road NE, Mailstop H16–3, Atlanta, 

Georgia 30329–4027; Telephone: (404) 

498–0730; Email: HICPAC@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Committee is charged 

with providing advice and guidance to 

the Director, Division of Healthcare 

Quality Promotion (DHQP), the Director, 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

the Director, CDC, the Secretary, Health 

and Human Services regarding (1) the 

practice of healthcare infection 

prevention and control; (2) strategies for 

surveillance, prevention, and control of 

infections, antimicrobial resistance, and 

related events in settings where 

healthcare is provided; and (3) periodic 

updating of CDC guidelines and other 

policy statements regarding prevention 

of healthcare-associated infections and 

healthcare-related conditions. 

Matters To Be Considered: The agenda 

will include the following updates: The 

Healthcare Personnel Guideline 

Workgroup; the Isolation Precautions 

Guideline Workgroup; and the Neonatal 

Intensive Care Unit Workgroup. Agenda 

items are subject to change as priorities 

dictate. 

Procedures for Public Comment: Time 

will be available for public comment. 

Members of the public who wish to 

provide public comments should plan 

to attend the public comment session at 

the start time listed. Please note that the 

public comment period may end before 

the time indicated, following the last 

call for comments. 

Procedures for Written Comment: The 

public may submit written comments in 

advance of the meeting. Comments 

should be submitted in writing by email 

to the contact person listed above. The 

deadline for receipt of written public 

comment is July 26, 2021. All requests 

must contain the name, address, and 

organizational affiliation of the speaker, 

as well as the topic being addressed. 

Written comments should not exceed 

one single-spaced typed page in length. 

Written comments received in advance 

of the meeting will be included in the 

official record of the meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–14008 Filed 6–30–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10516] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by August 2, 2021. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at: 

https://www.cms.gov/Regulations-andGuidance/Legislation/Paperwork

ReductionActof1995/PRA-Listing.html 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 


khammond on DSKJM1Z7X2PROD with NOTICES